Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations-Reference-Cited by-同舟云学术

Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations

Published:2024-06 Issue: Volume:18 Page:100489
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Tani Naoki,Ikematsu Hideyuki,Watanabe Haruka,Goto Takeyuki,Yanagihara Yuki,Kurata Yasuo,Harada Yukiko,Horiuchi Takahiko,Akashi Koichi,Shimono Nobuyuki,Chong Yong

Publisher

Elsevier BV

Reference21 articles.

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine 2020; 383:2603–2615. Available at: Doi: 10.1056/NEJMoa2034577.

2. Specific anti-SARS-CoV-2 humoral and cellular immune responses after booster dose of BNT162b2 Pfizer-BioNTech mRNA-based vaccine: Integrated study of adaptive immune system components;Busà;Front Immunol,2022

3. Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, et al. Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel. PLoS One 2022; 17:e0263942-. Available at: Doi: 10.1371/journal.pone.0263942.

4. Kim MS, Jung SY, Ahn JG, et al. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database. J Med Virol 2022; 94:1085–1095. Available at: Doi: 10.1002/jmv.27424.

5. Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine;Tani;Vaccine,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods;Vaccines;2024-07-21